FAQ

Johnson and Johnson

Known as: Johnson & Johnson 
health product manufacturer

Topic mentions per year

Topic mentions per year

1942-2017
05010019422016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Rivaroxaban in patients with a recent acute coronary syndrome.
BACKGROUND Acute coronary syndromes arise from coronary atherosclerosis with superimposed thrombosis. Since factor Xa plays a… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
BACKGROUND The use of warfarin reduces the rate of ischemic stroke in patients with atrial fibrillation but requires frequent… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2011
2011
Recent experience in health promotion at Johnson & Johnson: lower health spending, strong return on investment.
Johnson & Johnson Family of Companies introduced its worksite health promotion program in 1979. The program evolved and is still… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.
BACKGROUND Intravenous injection is the standard administration route of bortezomib; however, subcutaneous administration is an… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Early and mid-term results of drug-eluting stent implantation in unprotected left main.
BACKGROUND The safety and efficacy of percutaneous coronary intervention in unprotected left main (ULM) coronary arteries are… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer.
PURPOSE To determine whether addition of the farnesyltransferase inhibitor tipifarnib (Zarnestra, R115777; Johnson and Johnson… (More)
Is this relevant?
2002
2002
Long-term impact of Johnson & Johnson's Health & Wellness Program on health care utilization and expenditures.
The long-term impact of corporate health and wellness programs is largely unknown, because most evaluations focus on impact in… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2002
2002
The long-term impact of Johnson & Johnson's Health & Wellness Program on employee health risks.
To be viewed as successful, corporate health promotion and disease prevention programs must demonstrate that they can improve the… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Collaborative Learning Enhances Critical Thinking
The concept of collaborative learning, the grouping and pairing of students for the purpose of achieving an academic goal, has… (More)
  • table 1
Is this relevant?
1986
1986
Impact of worksite health promotion on health care costs and utilization. Evaluation of Johnson & Johnson's Live for Life program.
This study explores the relationship between exposure to a comprehensive worksite health promotion program and health care costs… (More)
Is this relevant?